M. Michallet

1.3k total citations
22 papers, 741 citations indexed

About

M. Michallet is a scholar working on Hematology, Infectious Diseases and Epidemiology. According to data from OpenAlex, M. Michallet has authored 22 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in M. Michallet's work include Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). M. Michallet is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). M. Michallet collaborates with scholars based in France, Belgium and United States. M. Michallet's co-authors include Stéphane Picot, Xavier Thomas, Marie‐Christine Nicolle, Philippe Vanhems, M. A. Piens, Didier Blaise, Anne‐Lise Bienvenu, Thomas Bénet, Nathalie Sorel and Thibaut Leguay and has published in prestigious journals such as The Lancet, Blood and Clinical Infectious Diseases.

In The Last Decade

M. Michallet

19 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Michallet France 13 328 265 226 203 203 22 741
P Fenaux France 7 181 0.6× 176 0.7× 134 0.6× 174 0.9× 92 0.5× 11 509
C Ferry France 14 480 1.5× 199 0.8× 324 1.4× 85 0.4× 289 1.4× 26 1.0k
Caitlin R. Rausch United States 13 559 1.7× 246 0.9× 238 1.1× 153 0.8× 278 1.4× 51 1.0k
J. A. C. Nery Brazil 15 213 0.6× 644 2.4× 371 1.6× 52 0.3× 69 0.3× 26 984
Ken Ishiyama Japan 17 555 1.7× 76 0.3× 141 0.6× 136 0.7× 186 0.9× 100 865
A Merlat France 7 181 0.6× 183 0.7× 79 0.3× 102 0.5× 49 0.2× 8 465
Étienne Daguindau France 17 222 0.7× 221 0.8× 215 1.0× 58 0.3× 197 1.0× 54 815
P Rousselot France 11 336 1.0× 132 0.5× 80 0.4× 269 1.3× 87 0.4× 32 613
Fumihiko Monma Japan 13 317 1.0× 70 0.3× 93 0.4× 120 0.6× 89 0.4× 35 496
Jamila Aboobaker South Africa 16 33 0.1× 113 0.4× 232 1.0× 98 0.5× 212 1.0× 32 722

Countries citing papers authored by M. Michallet

Since Specialization
Citations

This map shows the geographic impact of M. Michallet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Michallet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Michallet more than expected).

Fields of papers citing papers by M. Michallet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Michallet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Michallet. The network helps show where M. Michallet may publish in the future.

Co-authorship network of co-authors of M. Michallet

This figure shows the co-authorship network connecting the top 25 collaborators of M. Michallet. A scholar is included among the top collaborators of M. Michallet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Michallet. M. Michallet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dubois, Valérie, Marie Balsat, Sophie Ducastelle, et al.. (2025). HLA diversity is associated with TKI response and treatment‐free remission in chronic myeloid leukemia. HemaSphere. 9(11). e70261–e70261.
3.
Chevallier, Patrice, Myriam Labopin, Gèrard Socié, et al.. (2014). Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial. Haematologica. 99(9). 1486–1491. 22 indexed citations
5.
Chevallier, Patrice, Myriam Labopin, Nöel Milpied, et al.. (2013). Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation. 49(3). 361–365. 12 indexed citations
6.
Xhaard, Aliénor, Fanny Lanternier, Raphaël Porcher, et al.. (2012). Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008). Clinical Microbiology and Infection. 18(10). E396–E400. 63 indexed citations
7.
Lehot, Jean‐Jacques, Olivier Bastien, Bernard Allaouchiche, et al.. (2012). Candida albicansand non-Candida albicansfungemia in an institutional hospital during a decade. Medical Mycology. 51(1). 33–37. 41 indexed citations
8.
Nicolle, Marie‐Christine, Thomas Bénet, Anne‐Lise Bienvenu, et al.. (2011). Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. Haematologica. 96(11). 1685–1691. 58 indexed citations
9.
Michallet, M., Mohamad Sobh, Stéphane Morisset, et al.. (2011). Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole. Medical Mycology. 49(7). 1–7. 37 indexed citations
11.
Robinson, Stephen, Anna Sureda, Carmen Canals, et al.. (2008). Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome. Haematologica. 94(2). 230–238. 114 indexed citations
12.
Moreau, Philippe, Frédéric Garban, Michel Attal, et al.. (2008). Long-Term Follow-up Results of IFM9903 and IFM9904 Trials Comparing Non Myeloablative Allotransplantation with Autologous Transplantation in High-Risk De Novo Multiple Myeloma.. Blood. 112(11). 1126–1126. 4 indexed citations
13.
Bénet, Thomas, Marie‐Christine Nicolle, M. A. Piens, et al.. (2007). Reduction of Invasive Aspergillosis Incidence among Immunocompromised Patients after Control of Environmental Exposure. Clinical Infectious Diseases. 45(6). 682–686. 55 indexed citations
14.
Hébuterne, Xavier, C. Beauvillain de Montreuil, É. Lemarié, M. Michallet, & François Goldwasser. (2007). O017 Effets des cancers sur l’état nutritionnel et la prise alimentaire : la perception des malades. Nutrition Clinique et Métabolisme. 21. 39–39. 6 indexed citations
16.
Piens, M. A., et al.. (2004). Intérêt de la détection d'antigène aspergillaire dans le liquide céphalo-rachidien en cas de suspicion d'aspergillose cérébrale. Journal de Mycologie Médicale. 14(1). 28–33. 1 indexed citations
17.
Michallet, M., Florence Persat, N Kranzhöfer, et al.. (1998). Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation. Bone Marrow Transplantation. 21(12). 1239–1243. 27 indexed citations
18.
Cordonnier, Catherine, et al.. (1996). Complications pulmonaires des greffes de cellules souches hématopoïétiques. Revue des Maladies Respiratoires. 13(5).
19.
Blaise, Didier, Daniel Olive, D Maraninchi, et al.. (1995). Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis. The Lancet. 345(8958). 1144–1146. 54 indexed citations
20.
Jj, Sotto, Élisabeth Brambilla, M. Michallet, et al.. (1982). Non-Hodgkin's malignant lymphomas: a cytologic classification based on statistical analysis and correlated with prognosis.. PubMed. 4(1). 6–24. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026